back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-23 14:00 Tx date 2025-06-18 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,850
+110,637 vol $0.55 each |
223,765 | |
| Filed 2025-01-15 11:02 Tx date 2025-01-09 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,787
+56,890 vol $0.84 each |
113,128 | |
| Filed 2024-12-20 17:11 Tx date 2024-12-20 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$288,000
+320,000 vol $0.90 each |
7,879,000 | |
| Filed 2024-10-09 17:52 Tx date 2024-10-09 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$427,499
+750,000 vol $0.57 each |
7,559,000 | |
| Filed 2024-03-27 16:58 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
113,793 | |
| Filed 2023-11-22 16:51 Tx date 2023-11-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$134,821
+23,529 vol $5.73 each |
784,404 | |
| Filed 2023-11-09 16:02 Tx date 2023-11-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$98,661
+16,471 vol $5.99 each |
760,875 | |
| Filed 2023-11-09 16:01 Tx date 2023-11-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$321,240
+60,000 vol $5.35 each |
744,404 | |
| Filed 2023-09-12 20:43 Tx date 2023-09-07 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,057
+56,238 vol $0.41 each |
56,238 | |
| Filed 2023-09-12 20:41 Tx date 2023-06-29 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-09-12 20:41 Tx date 2023-06-29 |
$MSCL
Satellos Bioscience Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,809,000 | ||
| Filed 2023-03-23 21:06 Tx date 2023-03-21 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+36,000 vol |
224,889 | |
| Filed 2023-01-05 13:36 Tx date 2022-12-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-83,088.28
-34,334 vol $2.42 each |
684,404 | |
| Filed 2023-01-05 13:36 Tx date 2022-12-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-91,312.49
-37,889 vol $2.41 each |
718,738 | |
| Filed 2023-01-05 13:35 Tx date 2022-12-20 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-110,351.01
-43,617 vol $2.53 each |
756,627 | |
| Filed 2023-01-05 13:34 Tx date 2022-12-16 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-133,500
-50,000 vol $2.67 each |
800,244 | |
| Filed 2023-01-05 13:33 Tx date 2022-12-15 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-143,000
-50,000 vol $2.86 each |
850,244 | |
| Filed 2023-01-05 13:32 Tx date 2022-12-15 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-92,800
-32,000 vol $2.90 each |
900,244 | |
| Filed 2023-01-05 13:32 Tx date 2022-12-14 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-75,000
-25,000 vol $3.00 each |
932,244 | |
| Filed 2022-10-27 13:27 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
63,793 | |
| Filed 2022-06-02 13:09 Tx date 2022-05-31 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$78,000
+7,552 vol $10.33 each |
65,256 | |
| Filed 2022-02-25 22:24 Tx date 2022-02-23 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+60,000 vol |
188,889 | |
| Filed 2021-06-01 17:04 Tx date 2021-05-31 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$78,004
+16,857 vol $4.63 each |
57,704 | |
| Filed 2021-03-03 18:25 Tx date 2021-02-22 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,539,000
+57,000 vol $27.00 each |
957,244 | |
| Filed 2021-03-01 19:20 Tx date 2021-02-25 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
128,889 | |
| Filed 2020-12-14 18:49 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
41,293 | |
| Filed 2020-12-14 14:48 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,321.04
-2,184 vol $3.81 each |
31,566 | |
| Filed 2020-12-14 14:48 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,136
-6,534 vol $4.00 each |
33,750 | |
| Filed 2020-12-14 14:48 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-80,750
-25,000 vol $3.23 each |
40,284 | |
| Filed 2020-12-14 14:47 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,864
-1,716 vol $4.00 each |
65,284 | |
| Filed 2020-12-14 14:47 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$31,629
+6,773 vol $4.67 each |
900,244 | |
| Filed 2020-12-14 14:46 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,321
+2,184 vol $3.81 each |
893,471 | |
| Filed 2020-12-14 14:46 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,321
+2,184 vol $3.81 each |
||
| Filed 2020-12-14 14:45 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
884,753 | |
| Filed 2020-12-14 14:45 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,864
+1,716 vol $4.00 each |
859,753 | |
| Filed 2020-12-14 14:44 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,629.91
-6,773 vol $4.67 each |
24,793 | |
| Filed 2020-12-14 14:42 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$31,629
+6,773 vol $4.67 each |
||
| Filed 2020-12-14 14:41 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,321
+2,184 vol $3.81 each |
||
| Filed 2020-12-14 14:40 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,136
+6,534 vol $4.00 each |
891,287 | |
| Filed 2020-12-14 14:39 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
| Filed 2020-12-14 14:38 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,864
+1,716 vol $4.00 each |
||
| Filed 2020-12-14 14:37 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,629.91
-6,773 vol $4.67 each |
||
| Filed 2020-12-14 14:36 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,321.04
-2,184 vol $3.81 each |
||
| Filed 2020-12-14 14:36 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,136
-6,534 vol $4.00 each |
||
| Filed 2020-12-14 14:35 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-80,750
-25,000 vol $3.23 each |
||
| Filed 2020-12-14 14:34 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,864
-1,716 vol $4.00 each |
||
| Filed 2020-12-14 14:33 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
| Filed 2020-12-14 14:33 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,864
+1,716 vol $4.00 each |
||
| Filed 2020-12-14 14:33 Tx date 2020-12-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,136
+6,534 vol $4.00 each |
||
| Filed 2020-12-14 14:33 Tx date 2020-12-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
| Filed 2020-12-14 14:28 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
| Filed 2020-12-14 14:25 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,321
+2,184 vol $3.81 each |
||
| Filed 2020-12-14 14:24 Tx date 2020-12-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,136
+6,534 vol $4.00 each |
||
| Filed 2020-12-14 14:23 Tx date 2020-12-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
| Filed 2020-12-14 14:22 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,864
+1,716 vol $4.00 each |
||
| Filed 2020-12-14 14:21 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$27,456
+6,864 vol $4.00 each |
||
| Filed 2020-12-14 14:18 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$27,456
+6,864 vol $4.00 each |
||
| Filed 2020-12-14 14:07 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,629.91
-6,773 vol $4.67 each |
||
| Filed 2020-12-14 14:04 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,321.04
-2,184 vol $3.81 each |
||
| Filed 2020-12-14 14:01 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,136
-6,534 vol $4.00 each |
||
| Filed 2020-12-14 14:00 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-80,750
-25,000 vol $3.23 each |
||
| Filed 2020-12-14 13:57 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,864
-1,716 vol $4.00 each |
65,284 | |
| Filed 2020-12-14 13:57 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,864
-1,716 vol $4.00 each |
||
| Filed 2020-10-22 15:01 Tx date 2020-10-22 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$399,998
+177,777 vol $2.25 each |
698,918 | |
| Filed 2020-08-25 13:59 Tx date 2020-08-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$171,024
+24,088 vol $7.10 each |
858,037 | |
| Filed 2020-08-25 13:58 Tx date 2020-08-20 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$138,370
+19,529 vol $7.09 each |
833,949 | |
| Filed 2020-08-25 13:57 Tx date 2020-08-19 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$349,280
+50,000 vol $6.99 each |
814,420 | |
| Filed 2020-08-21 14:13 Tx date 2020-08-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$680,000
+100,000 vol $6.80 each |
764,420 | |
| Filed 2020-08-21 14:12 Tx date 2020-08-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,600
+7,000 vol $6.80 each |
664,420 | |
| Filed 2020-08-04 13:09 Tx date 2020-07-31 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$600,000
+100,000 vol $6.00 each |
657,420 | |
| Filed 2020-06-01 16:57 Tx date 2020-05-31 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$78,000
+5,373 vol $14.52 each |
40,847 | |
| Filed 2020-05-21 16:28 Tx date 2020-05-19 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,219
+5,555 vol $4.36 each |
521,141 | |
| Filed 2020-05-21 16:27 Tx date 2020-05-19 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$21,000
+16,667 vol $1.26 each |
515,586 | |
| Filed 2020-05-21 16:26 Tx date 2020-05-19 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,999
+11,111 vol $1.08 each |
498,919 | |
| Filed 2020-05-21 16:26 Tx date 2020-05-19 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$75,000
+41,667 vol $1.80 each |
487,808 | |
| Filed 2020-05-21 16:25 Tx date 2020-05-19 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,219.80
-5,555 vol $4.36 each |
88,889 | |
| Filed 2020-05-21 16:24 Tx date 2020-05-19 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-21,000.42
-16,667 vol $1.26 each |
94,444 | |
| Filed 2020-05-21 16:23 Tx date 2020-05-19 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,999.88
-11,111 vol $1.08 each |
111,111 | |
| Filed 2020-05-21 16:22 Tx date 2020-05-19 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-75,000.60
-41,667 vol $1.80 each |
122,222 | |
| Filed 2020-04-01 18:09 Tx date 2020-04-01 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
163,889 | |
| Filed 2020-03-02 18:34 Tx date 2020-03-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,584
+916 vol $5.00 each |
557,420 | |
| Filed 2020-03-02 18:33 Tx date 2020-03-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$67,685
+14,094 vol $4.80 each |
556,504 | |
| Filed 2020-02-28 16:28 Tx date 2020-02-26 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Cash Incentive Compensation Units
38 - Redemption, retraction, cancellation, repurchase
|
-5,093 vol |
0 | |
| Filed 2020-02-24 13:39 Tx date 2020-02-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540,000
+100,000 vol $5.40 each |
542,410 | |
| Filed 2020-02-20 16:20 Tx date 2020-02-20 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$270,000
+50,000 vol $5.40 each |
442,410 | |
| Filed 2020-02-20 16:19 Tx date 2020-02-19 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$805,860
+150,000 vol $5.37 each |
392,410 | |
| Filed 2020-02-20 16:17 Tx date 2020-02-19 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$158,764
+29,565 vol $5.37 each |
242,410 | |
| Filed 2020-01-17 17:10 Tx date 2020-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-273,843 vol |
212,845 | |
| Filed 2020-01-17 17:07 Tx date 2020-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-273,843 vol |
||
| Filed 2019-11-01 15:35 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
67,000 | |
| Filed 2019-11-01 15:04 Tx date 2019-10-31 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,255
+7,000 vol $4.61 each |
486,688 | |
| Filed 2019-10-21 15:57 Tx date 2019-10-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,154
+2,000 vol $3.58 each |
464,688 | |
| Filed 2019-10-18 17:16 Tx date 2019-10-18 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$55,140
+15,000 vol $3.68 each |
477,688 | |
| Filed 2019-10-16 13:33 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
42,000 | |
| Filed 2019-09-09 19:58 Tx date 2019-09-09 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$106,500
+15,000 vol $7.10 each |
446,141 | |
| Filed 2019-08-20 16:57 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-361,111 vol |
138,889 | |
| Filed 2019-08-20 16:56 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
37 - Stock split or consolidation
|
-92,231 vol |
35,474 | |
| Filed 2019-08-20 16:56 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Contingent value right (CVR)
37 - Stock split or consolidation
|
-76,556 vol |
29,444 | |
| Filed 2019-08-20 16:55 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,120,967 vol |
431,141 | |
| Filed 2019-08-20 16:54 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Cash Incentive Compensation Units
37 - Stock split or consolidation
|
-13,240 vol |
5,093 | |
| Filed 2019-06-24 10:31 Tx date 2019-06-21 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$139,945
+50,000 vol $2.80 each |
1,552,108 | |
| Filed 2019-06-24 10:30 Tx date 2019-06-20 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$134,925
+50,000 vol $2.70 each |
1,502,108 | |
| Filed 2019-05-31 14:26 Tx date 2019-05-31 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$52,500
+36,001 vol $1.46 each |
127,705 | |
| Filed 2019-02-21 Tx date 2019-02-20 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
500,000 | |
| Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,050
+5,000 vol $3.81 each |
17,000 | |
| Filed 2018-12-18 Tx date 2018-12-18 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,000
+263,158 vol $0.95 each |
1,452,108 | |
| Filed 2018-05-31 Tx date 2018-05-31 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$52,500
+91,704 vol $0.57 each |
91,704 | |
| Filed 2018-05-31 Tx date 2012-05-25 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-228,000 vol |
12,000 | |
| Filed 2018-04-25 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-3,314,204 vol |
462,688 | |
| Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-267,500
-50,000 vol $5.35 each |
0 | |
| Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,000
+190,000 vol $0.20 each |
240,000 | |
| Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,000
+50,000 vol $0.20 each |
50,000 | |
| Filed 2018-02-23 Tx date 2018-02-20 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
400,000 | |
| Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,848
+58,400 vol $0.22 each |
3,586,892 | |
| Filed 2018-01-19 Tx date 2018-01-16 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,100
+10,000 vol $0.21 each |
||
| Filed 2018-01-19 Tx date 2018-01-16 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,100
+10,000 vol $0.21 each |
3,498,636 | |
| Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,717
+29,856 vol $0.225 each |
3,528,492 | |
| Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,848
+58,400 vol $0.22 each |
||
| Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,500
+150,000 vol $0.21 each |
3,736,892 | |
| Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,396
+40,000 vol $0.2099 each |
3,776,892 | |
| Filed 2018-01-19 Tx date 2018-01-18 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,717
+29,856 vol $0.225 each |
||
| Filed 2018-01-16 Tx date 2018-01-09 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$625,000
+3,125,000 vol $0.20 each |
3,488,636 | |
| Filed 2017-12-15 Tx date 2017-12-12 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$448,001
+1,178,950 vol $0.38 each |
1,188,950 | |
| Filed 2017-05-24 Tx date 2017-05-23 |
$BLU
BELLUS Health Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
250,000 | |
| Filed 2015-07-13 Tx date 2015-03-05 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-13 Tx date 2015-07-10 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+363,636 vol |
363,636 | |
| Filed 2015-07-13 Tx date 2015-07-10 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-363,636 vol |
0 | |
| Filed 2015-06-05 Tx date 2015-03-15 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-05 Tx date 2015-03-05 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
363,636 | ||
| Filed 2015-06-05 Tx date 2015-03-05 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 |